Please provide your email address to receive an email when new articles are posted on . Less than 40% of the studied veteran cohort were adherent to their inhaled COPD medications. Adherence was found ...

In patients with asthma, the use of inhaler electronic medication monitors with both rescue and controller inhalers is associated with higher adherence to these devices. In patients with asthma, the ...

Add Yahoo as a preferred source to see more of our stories on Google. Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the ...

The cost profile of single maintenance and reliever therapy, also known as SMART or single-inhaler therapy, was “favorable” ...

Asthma inhalers can be for quick relief or long-term control. Rescue inhalers work by relaxing your airway muscles to help you breathe better. People with chronic asthma may need a daily inhaler to ...

The FDA should make more safe drugs available for over-the-counter purchase, starting with albuterol, in order to reduce costs and increase access to medicine.

Both products deliver dry powder asthma medication through Teva’s RespiClick inhaler. The AirDuo RespiClick contains the same active ingredients as GlaxoSmithKline’s inhaler drug Advair, while the ...

(AP) A panel of respiratory experts has voted in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravence for treating chronic lung disease. A majority of Food and Drug ...

Adherium, the Australian connected inhaler company that partnered with AstraZeneca earlier this summer, has released data from three small studies of the company's Smartinhaler system. Data from the ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could jeopardize ...

Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim. Following ...